Avadel Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Avadel Pharmaceuticals Stock Summary

Avadel Pharmaceuticals competes with Neurocrine Biosciences, Ironwood Pharmaceuticals, Alkermes Plc, Intracellular, and Dynavax Technologies. Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland. Avadel Pharmaceuticals is traded on NASDAQ Exchange in the United States.

Avadel Pharmaceuticals Key Financial Ratios

Avadel Pharmaceuticals Key Balance Sheet Accounts

Avadel Pharmaceuticals Key Income Statement Accounts

Avadel Pharmaceuticals Key Cash Accounts

Avadel Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Avadel Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Avadel Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avadel Pharmaceuticals competition to find correlations between indicators driving Avadel Pharmaceuticals's intrinsic value. More Info.Avadel Pharmaceuticals PLC is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Avadel Pharmaceuticals' Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Avadel Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Avadel Pharmaceuticals Systematic Risk

Today, most investors in Avadel Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Avadel Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Avadel Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Avadel Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Avadel Pharmaceuticals PLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of Avadel Pharmaceuticals PLC based on widely used predictive technical indicators. In general, we focus on analyzing Avadel Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Avadel Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.